PAPER Khan MS, Hegde V
SEARCH RESULTS
309 RESULTS
PAPER Al Mamun A, Maříková J, Hulcová D, Janoušek J, Šafratová M, Nováková L, Kučera T, Hrabinová M, Kuneš J, Korábečný J, Cahlíková L
Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase.
Biomolecules. 2020 May 22;10(5) PubMed: 32455879PAPER Srejovic I, Selakovic D, Jovicic N, Jakovljević V, Lukic ML, Rosic G
Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior.
Biomolecules. 2020 May 21;10(5) PubMed: 32455781PAPER Gadhave K, Kumar P, Kapuganti SK, Uversky VN, Giri R
Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases.
Biomolecules. 2020 May 21;10(5) PubMed: 32455657PAPER DiLEK E
Activation of Two Different Drugs Used in Alzheimer's Disease Treatment on Human Carbonic Anhydrase Isozymes I and II Activity: an In Vitro Study.
Turk J Pharm Sci. 2017 Aug;14(2):164-168. Epub 2017 Aug 15 PubMed: 32454608PAPER Biazus-Sehn LF, Schuch FB, Firth J, Stigger FS
Effects of physical exercise on cognitive function of older adults with mild cognitive impairment: A systematic review and meta-analysis.
Arch Gerontol Geriatr. 2020 Jul - Aug;89:104048. Epub 2020 May 12 PubMed: 32460123PAPER Hustad E, Aasly JO
Clinical and Imaging Markers of Prodromal Parkinson's Disease.
Front Neurol. 2020;11:395. Epub 2020 May 8 PubMed: 32457695PAPER Woo Y, Lim JS, Oh J, Lee JS, Kim JS
Neuroprotective Effects of Euonymus alatus Extract on Scopolamine-Induced Memory Deficits in Mice.
Antioxidants (Basel). 2020 May 22;9(5) PubMed: 32456069"Brain Barriers Virtual 2020 (BBV2020)": Rethinking BBB Tight Junctions
CONFERENCE 2020-06-10 00:00:00-2020-06-10 00:00:00 Online Zoom Meeting 10 June 2020 Organizers: Bjoern Bauer, University of Kentucky, Anika Hartz, University of Kentucky, Brandon Kim, University of Wisconsin, Madison Speaker: Ayal Ben-Zvi, PhD, The Hebrew University of Jerusalem Meeting time: 12 PM EDT To
PAPER Olanow CW, Factor SA, Espay AJ, Hauser RA, Shill HA, Isaacson S, Pahwa R, Leinonen M, Bhargava P, Sciarappa K, Navia B, Blum D, CTH-300 Study investigators
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Neurol. 2020 Feb;19(2):135-144. Epub 2019 Dec 7 PubMed: 31818699PAPER Hauser RA, Olanow CW, Dzyngel B, Bilbault T, Shill H, Isaacson S, Dubow J, Agro A
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.
Mov Disord. 2016 Sep;31(9):1366-72. Epub 2016 Jul 19 PubMed: 27430123PAPER Borkar N, Mu H, Holm R
Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.
Asian J Pharm Sci. 2018 Nov;13(6):507-517. Epub 2017 Dec 6 PubMed: 32104425PAPER Auffret M, Drapier S, Vérin M
The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.
Drugs R D. 2018 Jun;18(2):91-107. PubMed: 29546602PAPER Bilbault T, Taylor S, Walker R, Grundy SL, Pappert EJ, Agro A
Buccal mucosal irritation studies of sublingual apomorphine film (APL-130277) in Syrian golden hamsters.
Ther Deliv. 2016 Sep;7(9):611-8. Epub 2016 Aug 10 PubMed: 27506115Kynmobi
THERAPEUTICS (9R)-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol Sunovion Pharmaceuticals Inc. APL-130277 apomorphine hydrochloride sublingual thin film Small Molecule Other Neurotransmitters Starting in August 2014, a
Current Filters
- Date Range : May 2020 to Jun 2020 x